Immunoglobulin A: strategic defense initiative at the mucosal surface.
about
The structure and function of human IgAExpression cloning of a human Fc receptor for IgAThe polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgALocalization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland BioreactorEndocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptorsWegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunityEffect of music and auditory stimuli on secretory immunoglobulin A (IgA).Antibodies enhance interaction of Vibrio cholerae with intestinal M-like cells.P-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogensTargeting mucosal sites by polymeric immunoglobulin receptor-directed peptidesAssociation of type II immunoglobulin G-binding protein expression and survival of group A streptococci in human blood.Isolation and expression of the gene for a major surface protein of Giardia lamblia.Respiratory mucosal immunization with reovirus serotype 1/L stimulates virus-specific humoral and cellular immune responses, including double-positive (CD4(+)/CD8(+)) T cells.Evolution of duplicated IgH loci in Atlantic salmon, Salmo salarDirect interaction between Rab3D and the polymeric immunoglobulin receptor and trafficking through regulated secretory vesicles in lacrimal gland acinar cells.Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.Cysteine proteinases and the pathogenesis of amebiasis.Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytesA pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology.Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses.Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA.Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniaeSelective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal diseaseImmunoglobulin A response in murine schistosomiasis: stimulatory role of egg antigens.Urinary tract infections: new insights into a common problem.Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.Recombinant human IgA expressed in insect cells.Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteinsImmunoglobulin (Ig) mu, kappa transgenic mice express transgenic idiotype on endogenously rearranged IgM and IgA molecules by secretion of chimeric moleculesAltered hepatic transport of immunoglobulin A in mice lacking the J chain.A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretion.Transcytosis of staphylococcal superantigen toxins.Sublingual vaccination with influenza virus protects mice against lethal viral infection.Protective murine monoclonal antibodies to Cryptococcus neoformans
P2860
Q24307588-8D68610E-B7AF-454B-AB2C-C676752DDE2FQ24322722-DB7BDCE0-33DB-42EE-AA7D-C556F32D2FFAQ24561540-EFB02922-EA7B-4625-A827-0AE134DB8054Q24678296-7FB10983-0F4D-4CD5-8856-EAAC4C707C57Q26745000-69454A41-3419-46BC-A376-F5EDD6459A7EQ28388054-4502B4F5-8CE6-400E-AA7E-F16EDC35B508Q28393433-CF87A9D0-8602-4964-ACDC-1FC43FA78627Q30312650-DF822DAC-E43D-4DBA-BFE6-CBA4C17061D0Q30478467-B2DEC2CB-AEF8-4CD1-8BD6-EF4E6E30A2C2Q30558351-39EE4C0B-E492-4D5B-AFEE-E15B098A901BQ30843893-2FFE264A-5E09-4F45-B47F-5208D030A045Q33607547-8B7758E3-2C41-4761-967D-8C36D5102F60Q33627731-E80C8466-F8A6-475C-85FC-01D2085E44AEQ33650122-2CC5269A-BDA1-49AB-BFA2-A331B63959DBQ33682875-D1DAC81B-0DB3-404A-9F8B-A4200C1EE0C6Q33715498-060D1B50-EFB1-4597-A754-088320521E61Q33834576-2FBA53B0-2F15-416B-83D4-758B216ABAB4Q33859127-FABF1371-3A32-4D23-93F1-4ED53026EF82Q33886180-40EF8CF1-C081-4BAF-B349-717E1595E6EFQ34008338-F423F2F9-02FC-41CE-ADA4-E0324C9FD80AQ34066431-F7F64405-CD72-4BE5-9BCE-F4D28F876F7AQ34219793-90CF8A4B-1C73-4A4E-8C21-CE54CDDA7BB2Q34222728-2F6FA333-90F2-4F03-ADE3-BDD0BE28C3CEQ34431600-5ED5A59A-CBB7-4D1F-BA7D-662EE4E8C5F5Q34912887-61227B3C-2726-46FA-B7DC-DDC26DBC0689Q35224726-E4F2F922-AD10-4DF4-AE22-A92BA32EFD36Q35431790-A580CDE7-44A5-400C-B4DE-5506B421E615Q35472309-2B9C4B22-19C3-4570-A668-F819D6F92C96Q35521227-326F443A-1AF8-48AD-9496-807EF359AC02Q35526521-28D7DB6B-5F14-420E-BE93-C661F1F29CF1Q35698255-9500FEB9-853E-44ED-89D5-1DA9467FB5FBQ35768825-1825893A-7D42-4567-A72C-59FAABF67FE4Q35897726-E979D797-9113-4E24-B80C-E220354345F1Q36220664-1119E976-62C8-484F-A24F-6DEE98FFDDB0Q36231870-515B9F51-54F3-4017-8521-FDCA08521B67Q36365566-D983E772-0848-49E5-BE08-9864866FF82CQ36367780-C8F25C3A-765D-4E23-A234-CDFAF213E1E2Q36377151-D9D1D911-574B-4CE8-8CC6-35770D5907A5Q36446440-1C4B4D3F-A80E-4FDF-AB87-8D97FA388B78Q36969771-629F5899-79AA-4298-83A2-20E159C939C2
P2860
Immunoglobulin A: strategic defense initiative at the mucosal surface.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@ast
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@en
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@nl
type
label
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@ast
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@en
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@nl
prefLabel
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@ast
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@en
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@nl
P1476
Immunoglobulin A: strategic defense initiative at the mucosal surface.
@en
P2093
Underdown BJ
P304
P356
10.1146/ANNUREV.IY.04.040186.002133
P577
1986-01-01T00:00:00Z